Medications

New therapeutic option for head and neck carcinomas

The various manifestations of head and neck carcinomas rank sixth in frequency worldwide and are fatal for about half a million people every year. In a quarter of cases, head and neck squamous cell carcinoma (HNSCC) is caused ...

Oncology & Cancer

Fundamental cancer metabolism dogma revisited

A new paper in Nature Communications reveals new insights into adaptations made by cancer cells to rewire their metabolism to achieve growth and survive. Among the discoveries include a challenge to a well-known feature in ...

Medications

Cemiplimab prolongs survival in recurrent cervical cancer

(HealthDay)—For patients with recurrent cervical cancer after first-line platinum-containing chemotherapy, survival is significantly longer with cemiplimab than with single-agent chemotherapy, according to a study published ...

Medical research

How skin cells form a first line of defense against cancer

A study published today in Cell Reports reveals important insights into the molecular mechanisms that underpin the body's natural defenses against the development of skin cancer. The findings offer new clues into the behavior ...

Oncology & Cancer

New device to diagnose skin cancer

In the United States alone, about 3.3 million people are diagnosed with basal and squamous cell cancers (skin cancers) per year. Skin cancer is still detected using visual examination, a method of limited reliability for ...

Oncology & Cancer

Real-world evidence on minimally invasive and open esophagectomy

A group led by Prof. Ke Yang of Peking University Cancer Hospital released real-world evidence evaluating outcomes of minimally invasive esophagectomy (MIE) compared with open esophagectomy (OE) in localized esophageal squamous ...

page 2 from 37